Stocks
Latest stock market news — earnings, indices, equities, and corporate events explained for retail investors.
1840 articles in Stocks — page 51 of 154
StocksNorway's Oslo OBX Index Rises 0.56% as Healthcare and Utilities Lead Gains
Norway's stock market closed higher, driven by gains in healthcare and utilities sectors, with notable winners and losers.
StocksIsraeli Stocks Rise as Technology and Biomed Sectors Lead Gains
Israeli shares closed higher, driven by gains in technology and biomed sectors, with the TA 35 index up 0.53%.
StocksDoximity Stock Rated Strong Buy After CFO Resignation
Raymond James maintains a Strong Buy rating for Doximity following the resignation of its CFO.
StocksGreece's Stock Market Declines as Key Sectors Struggle
Greek shares fell on Monday, led by losses in banking and telecom sectors, with the Athens General Composite down 2.14%.
StocksAEVEX Stock Jumps 30% Following Strong IPO Performance
AEVEX Corp. shares rose 30% to $35.8, continuing a strong post-IPO rally after raising $320 million.
StocksRocket Lab Stock Climbs 5% Following Positive Analyst Insights
Rocket Lab shares increased 5% after an analyst raised the price target and praised the company's growth.
StocksScotiabank Maintains Underperform Rating on AST SpaceMobile Amid Launch Concerns
Scotiabank keeps a cautious stance on AST SpaceMobile, citing satellite deployment issues and mission failures.
StocksFermi Announces Leadership Changes and Strategic Restructuring
Fermi's recent restructuring aims to enhance its operations, despite significant stock decline.
StocksUBS Maintains Neutral Rating on PPL Amid Rhode Island Rate Case Developments
UBS keeps a Neutral rating on PPL Corp as Rhode Island's rate case progresses, highlighting regulatory challenges.
StocksRBC Maintains Outperform Rating for Rayonier Advanced Materials Amid Strategy Review
RBC Capital keeps an Outperform rating on Rayonier Advanced Materials after a strategic review announcement.
StocksUBS Maintains Buy Rating on Merck Stock Amid Strong Drug Pipeline
UBS reaffirms a Buy rating for Merck, citing a strong drug pipeline and recent FDA developments.
StocksUBS Maintains Positive Outlook on Hasbro Stock Amid Wizards Growth
UBS reaffirms a Buy rating for Hasbro, highlighting strong demand for Wizards of the Coast products.